NCT01165983: The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes |
|
|
| Completed | N/A | 124 | US | Placebo, Aliskiren, Trade name: Tekturna | Beth Israel Deaconess Medical Center, Novartis Pharmaceuticals | Diabetes Type 2 | 01/12 | | | |
NCT01252238: Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance |
|
|
| Terminated | N/A | 24 | US | Aliskiren, Valsartan and Aliskiren, Amlodipine | Brigham and Women's Hospital | Insulin Sensitivity, Aortic Compliance, Diastolic Function | 12/12 | 12/12 | | |
